Completed NA INTERVENTIONAL 3-arm NCT02509858

The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, in Type 2 Diabetes Mellitus.

The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, at All Stages of Type 2 Diabetes Mellitus.

Sponsor: Attikon Hospital

Conditions Diabetes Mellitus

Interventions A meal (730kcal, 50%carbohydrate, of which 38% was starch, 40% fat, and 10% protein) Placebo thyroxine

Updated 5 times since 2017 Last updated: Jul 27, 2015 Started: Feb 28, 2009 Primary completion: Feb 28, 2014 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetes Mellitus, this trial is completed. The trial is conducted by Attikon Hospital and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Attikon Hospital

Data source: Attikon Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.